Danae UroGeomics

Danae Urogenomics is a leading company in bladder cancer diagnostics. Our cutting-edge diagnostic systems allow us to offer high-quality services for the detection and monitoring of this disease. We collaborate with scientific institutions and hospitals to continuously improve our diagnostic and prognostic methods. We work with scientific collaborations and institutions to ensure the accuracy and effectiveness of our diagnostics.

woman in white scrub suit holding gray laptop computer

To provide innovative, non-invasive diagnostic solutions for bladder cancer, improving diagnostic accuracy and treatment effectiveness. Its goal is to reduce patient suffering, decrease healthcare costs, and advance the fight against cancer through research and cutting-edge technology.

Mission
Vision

To become global leaders in bladder cancer detection and treatment, setting new standards in diagnostics and patient care. They aspire to transform cancer management worldwide, offering tools that enable personalized treatments and significantly improve patient outcomes and quality of life.

Mission and Vision

BlaDiMir

BlaDiMir is an in vitro diagnostic system for detecting bladder cancer in urine through the measurement of specific microRNAs. It uses quantitative PCR (qPCR) technology to provide a precise and non-invasive diagnosis, improving accuracy and reducing the need for invasive procedures such as cystoscopy.
BlaDiMir+ not only focuses on detecting bladder cancer but also on predicting the response to Bacillus Calmette-Guérin (BCG) treatment, which is a standard therapy for non-muscle invasive bladder cancer (NMIBC).

BlaDiMir+

woman inside laboratory
woman inside laboratory

Products

Contact Us Now

Complete the form below to get in touch